A reversible gut sleeve could offer a new way to treat obesity
NCT ID NCT07675122
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This pilot study tests a temporary, flexible tube called a duodenal-jejunal bypass sleeve. It is placed in the upper intestine using an endoscope and left for 3 months to help with weight loss and improve metabolic syndrome. The study involves 20 adults with obesity or excess weight plus metabolic syndrome. Researchers will measure weight loss, body fat changes, and safety over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
duodenal-jejunal bypass sleeve
What this could lead to
If successful, this could offer a less invasive, reversible alternative to gastric bypass surgery for weight loss and metabolic syndrome.
What could go wrong
This is a small pilot study with only 20 participants, so results may not apply broadly. The sleeve is temporary (3 months) and long-term benefits are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CUHK Medical Centre
Shatin, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chinese University of Hong Kong
Shatin, Hong Kong
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact